nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—lung cancer	0.376	1	CbGaD
Oxaprozin—PTGS2—Cisplatin—lung cancer	0.0647	0.196	CbGbCtD
Oxaprozin—PTGS2—Etoposide—lung cancer	0.0636	0.192	CbGbCtD
Oxaprozin—PTGS1—Etoposide—lung cancer	0.0537	0.162	CbGbCtD
Oxaprozin—CYP2C9—Gefitinib—lung cancer	0.0505	0.153	CbGbCtD
Oxaprozin—CYP2C9—Teniposide—lung cancer	0.049	0.148	CbGbCtD
Oxaprozin—CYP2C9—Paclitaxel—lung cancer	0.0273	0.0827	CbGbCtD
Oxaprozin—CYP2C9—Cisplatin—lung cancer	0.022	0.0665	CbGbCtD
Oxaprozin—Flurbiprofen—UGT1A1—lung cancer	0.000567	0.19	CrCbGaD
Oxaprozin—Bifonazole—CYP2E1—lung cancer	0.00037	0.124	CrCbGaD
Oxaprozin—Fenbufen—PTGS2—lung cancer	0.000333	0.112	CrCbGaD
Oxaprozin—Warfarin—CYP1A1—lung cancer	0.000293	0.0982	CrCbGaD
Oxaprozin—Phenylbutazone—PTGS2—lung cancer	0.000191	0.0642	CrCbGaD
Oxaprozin—Phenprocoumon—ALB—lung cancer	0.000184	0.0616	CrCbGaD
Oxaprozin—Warfarin—ALB—lung cancer	0.000163	0.0547	CrCbGaD
Oxaprozin—Flurbiprofen—PTGS2—lung cancer	0.000156	0.0523	CrCbGaD
Oxaprozin—Propafenone—ABCB1—lung cancer	0.000152	0.051	CrCbGaD
Oxaprozin—Flurbiprofen—ALB—lung cancer	0.000139	0.0466	CrCbGaD
Oxaprozin—Infection—Paclitaxel—lung cancer	0.000136	0.000596	CcSEcCtD
Oxaprozin—Dyspnoea—Cisplatin—lung cancer	0.000136	0.000595	CcSEcCtD
Oxaprozin—Hyperhidrosis—Etoposide—lung cancer	0.000135	0.000592	CcSEcCtD
Oxaprozin—Feeling abnormal—Gemcitabine—lung cancer	0.000135	0.00059	CcSEcCtD
Oxaprozin—Shock—Paclitaxel—lung cancer	0.000135	0.00059	CcSEcCtD
Oxaprozin—Dizziness—Vinorelbine—lung cancer	0.000135	0.00059	CcSEcCtD
Oxaprozin—Abdominal pain upper—Doxorubicin—lung cancer	0.000135	0.00059	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Methotrexate—lung cancer	0.000134	0.000588	CcSEcCtD
Oxaprozin—Thrombocytopenia—Paclitaxel—lung cancer	0.000134	0.000587	CcSEcCtD
Oxaprozin—Tachycardia—Paclitaxel—lung cancer	0.000134	0.000586	CcSEcCtD
Oxaprozin—Anorexia—Etoposide—lung cancer	0.000133	0.000583	CcSEcCtD
Oxaprozin—Abdominal pain—Irinotecan—lung cancer	0.000133	0.000581	CcSEcCtD
Oxaprozin—Body temperature increased—Irinotecan—lung cancer	0.000133	0.000581	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000133	0.000581	CcSEcCtD
Oxaprozin—Decreased appetite—Cisplatin—lung cancer	0.000132	0.000581	CcSEcCtD
Oxaprozin—Hyperhidrosis—Paclitaxel—lung cancer	0.000132	0.00058	CcSEcCtD
Oxaprozin—Pneumonia—Methotrexate—lung cancer	0.000132	0.000578	CcSEcCtD
Oxaprozin—Anaemia—Docetaxel—lung cancer	0.000131	0.000576	CcSEcCtD
Oxaprozin—Drowsiness—Methotrexate—lung cancer	0.000131	0.000575	CcSEcCtD
Oxaprozin—Anorexia—Paclitaxel—lung cancer	0.000131	0.000572	CcSEcCtD
Oxaprozin—Hypotension—Etoposide—lung cancer	0.00013	0.000572	CcSEcCtD
Oxaprozin—Gastritis—Doxorubicin—lung cancer	0.00013	0.000571	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.00013	0.00057	CcSEcCtD
Oxaprozin—Vomiting—Vinorelbine—lung cancer	0.000129	0.000567	CcSEcCtD
Oxaprozin—Body temperature increased—Gemcitabine—lung cancer	0.000129	0.000566	CcSEcCtD
Oxaprozin—Renal failure—Methotrexate—lung cancer	0.000129	0.000565	CcSEcCtD
Oxaprozin—Rash—Vinorelbine—lung cancer	0.000128	0.000562	CcSEcCtD
Oxaprozin—Dermatitis—Vinorelbine—lung cancer	0.000128	0.000562	CcSEcCtD
Oxaprozin—Hypotension—Paclitaxel—lung cancer	0.000128	0.000561	CcSEcCtD
Oxaprozin—Stomatitis—Methotrexate—lung cancer	0.000128	0.00056	CcSEcCtD
Oxaprozin—Headache—Vinorelbine—lung cancer	0.000128	0.000559	CcSEcCtD
Oxaprozin—Syncope—Docetaxel—lung cancer	0.000128	0.000559	CcSEcCtD
Oxaprozin—Conjunctivitis—Methotrexate—lung cancer	0.000127	0.000559	CcSEcCtD
Oxaprozin—Asthma—Doxorubicin—lung cancer	0.000127	0.000558	CcSEcCtD
Oxaprozin—Leukopenia—Docetaxel—lung cancer	0.000127	0.000558	CcSEcCtD
Oxaprozin—Eosinophilia—Doxorubicin—lung cancer	0.000126	0.000553	CcSEcCtD
Oxaprozin—Palpitations—Docetaxel—lung cancer	0.000126	0.000551	CcSEcCtD
Oxaprozin—Feeling abnormal—Cisplatin—lung cancer	0.000126	0.00055	CcSEcCtD
Oxaprozin—Paraesthesia—Etoposide—lung cancer	0.000125	0.000549	CcSEcCtD
Oxaprozin—Haematuria—Methotrexate—lung cancer	0.000125	0.000548	CcSEcCtD
Oxaprozin—Loss of consciousness—Docetaxel—lung cancer	0.000125	0.000548	CcSEcCtD
Oxaprozin—Pancreatitis—Doxorubicin—lung cancer	0.000125	0.000547	CcSEcCtD
Oxaprozin—Dyspnoea—Etoposide—lung cancer	0.000124	0.000545	CcSEcCtD
Oxaprozin—Somnolence—Etoposide—lung cancer	0.000124	0.000544	CcSEcCtD
Oxaprozin—Insomnia—Paclitaxel—lung cancer	0.000124	0.000543	CcSEcCtD
Oxaprozin—Convulsion—Docetaxel—lung cancer	0.000123	0.00054	CcSEcCtD
Oxaprozin—Paraesthesia—Paclitaxel—lung cancer	0.000123	0.000539	CcSEcCtD
Oxaprozin—Hypertension—Docetaxel—lung cancer	0.000123	0.000538	CcSEcCtD
Oxaprozin—Agranulocytosis—Methotrexate—lung cancer	0.000122	0.000536	CcSEcCtD
Oxaprozin—Dyspnoea—Paclitaxel—lung cancer	0.000122	0.000535	CcSEcCtD
Oxaprozin—Somnolence—Paclitaxel—lung cancer	0.000122	0.000533	CcSEcCtD
Oxaprozin—Decreased appetite—Etoposide—lung cancer	0.000121	0.000532	CcSEcCtD
Oxaprozin—Pancytopenia—Doxorubicin—lung cancer	0.000121	0.00053	CcSEcCtD
Oxaprozin—Nausea—Vinorelbine—lung cancer	0.000121	0.00053	CcSEcCtD
Oxaprozin—Dyspepsia—Paclitaxel—lung cancer	0.000121	0.000528	CcSEcCtD
Oxaprozin—Body temperature increased—Cisplatin—lung cancer	0.00012	0.000528	CcSEcCtD
Oxaprozin—Asthenia—Irinotecan—lung cancer	0.00012	0.000528	CcSEcCtD
Oxaprozin—Constipation—Etoposide—lung cancer	0.000119	0.000523	CcSEcCtD
Oxaprozin—Dysuria—Doxorubicin—lung cancer	0.000119	0.000522	CcSEcCtD
Oxaprozin—Decreased appetite—Paclitaxel—lung cancer	0.000119	0.000522	CcSEcCtD
Oxaprozin—Dry mouth—Docetaxel—lung cancer	0.000118	0.000519	CcSEcCtD
Oxaprozin—Phenytoin—ALB—lung cancer	0.000118	0.0397	CrCbGaD
Oxaprozin—Haemoglobin—Methotrexate—lung cancer	0.000118	0.000518	CcSEcCtD
Oxaprozin—Haemorrhage—Methotrexate—lung cancer	0.000118	0.000516	CcSEcCtD
Oxaprozin—Hepatitis—Methotrexate—lung cancer	0.000118	0.000516	CcSEcCtD
Oxaprozin—Asthenia—Gemcitabine—lung cancer	0.000117	0.000514	CcSEcCtD
Oxaprozin—Constipation—Paclitaxel—lung cancer	0.000117	0.000513	CcSEcCtD
Oxaprozin—Confusional state—Docetaxel—lung cancer	0.000117	0.000513	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Doxorubicin—lung cancer	0.000116	0.000509	CcSEcCtD
Oxaprozin—Carbamazepine—ABCB1—lung cancer	0.000116	0.039	CrCbGaD
Oxaprozin—Oedema—Docetaxel—lung cancer	0.000116	0.000508	CcSEcCtD
Oxaprozin—Anaphylactic shock—Docetaxel—lung cancer	0.000116	0.000508	CcSEcCtD
Oxaprozin—Pruritus—Gemcitabine—lung cancer	0.000116	0.000507	CcSEcCtD
Oxaprozin—Infection—Docetaxel—lung cancer	0.000115	0.000505	CcSEcCtD
Oxaprozin—Feeling abnormal—Etoposide—lung cancer	0.000115	0.000504	CcSEcCtD
Oxaprozin—Hyperglycaemia—Doxorubicin—lung cancer	0.000115	0.000503	CcSEcCtD
Oxaprozin—Diarrhoea—Irinotecan—lung cancer	0.000115	0.000503	CcSEcCtD
Oxaprozin—Pneumonia—Doxorubicin—lung cancer	0.000114	0.0005	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Etoposide—lung cancer	0.000114	0.0005	CcSEcCtD
Oxaprozin—Shock—Docetaxel—lung cancer	0.000114	0.0005	CcSEcCtD
Oxaprozin—Thrombocytopenia—Docetaxel—lung cancer	0.000114	0.000498	CcSEcCtD
Oxaprozin—Drowsiness—Doxorubicin—lung cancer	0.000114	0.000498	CcSEcCtD
Oxaprozin—Tachycardia—Docetaxel—lung cancer	0.000113	0.000496	CcSEcCtD
Oxaprozin—Phenytoin—ABCB1—lung cancer	0.000113	0.0379	CrCbGaD
Oxaprozin—Feeling abnormal—Paclitaxel—lung cancer	0.000113	0.000494	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000113	0.000493	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000112	0.000491	CcSEcCtD
Oxaprozin—Diarrhoea—Gemcitabine—lung cancer	0.000112	0.00049	CcSEcCtD
Oxaprozin—Renal failure—Doxorubicin—lung cancer	0.000112	0.000489	CcSEcCtD
Oxaprozin—Erythema multiforme—Methotrexate—lung cancer	0.000111	0.000488	CcSEcCtD
Oxaprozin—Dizziness—Irinotecan—lung cancer	0.000111	0.000486	CcSEcCtD
Oxaprozin—Urticaria—Etoposide—lung cancer	0.000111	0.000486	CcSEcCtD
Oxaprozin—Stomatitis—Doxorubicin—lung cancer	0.000111	0.000485	CcSEcCtD
Oxaprozin—Jaundice—Doxorubicin—lung cancer	0.000111	0.000485	CcSEcCtD
Oxaprozin—Anorexia—Docetaxel—lung cancer	0.000111	0.000485	CcSEcCtD
Oxaprozin—Abdominal pain—Etoposide—lung cancer	0.00011	0.000484	CcSEcCtD
Oxaprozin—Body temperature increased—Etoposide—lung cancer	0.00011	0.000484	CcSEcCtD
Oxaprozin—Conjunctivitis—Doxorubicin—lung cancer	0.00011	0.000484	CcSEcCtD
Oxaprozin—Tinnitus—Methotrexate—lung cancer	0.00011	0.000481	CcSEcCtD
Oxaprozin—Asthenia—Cisplatin—lung cancer	0.000109	0.000479	CcSEcCtD
Oxaprozin—Urticaria—Paclitaxel—lung cancer	0.000109	0.000477	CcSEcCtD
Oxaprozin—Hypotension—Docetaxel—lung cancer	0.000108	0.000475	CcSEcCtD
Oxaprozin—Haematuria—Doxorubicin—lung cancer	0.000108	0.000474	CcSEcCtD
Oxaprozin—Body temperature increased—Paclitaxel—lung cancer	0.000108	0.000474	CcSEcCtD
Oxaprozin—Abdominal pain—Paclitaxel—lung cancer	0.000108	0.000474	CcSEcCtD
Oxaprozin—Vomiting—Irinotecan—lung cancer	0.000107	0.000468	CcSEcCtD
Oxaprozin—Sinusitis—Doxorubicin—lung cancer	0.000107	0.000467	CcSEcCtD
Oxaprozin—Agranulocytosis—Doxorubicin—lung cancer	0.000106	0.000464	CcSEcCtD
Oxaprozin—Rash—Irinotecan—lung cancer	0.000106	0.000464	CcSEcCtD
Oxaprozin—Dermatitis—Irinotecan—lung cancer	0.000106	0.000463	CcSEcCtD
Oxaprozin—Headache—Irinotecan—lung cancer	0.000105	0.000461	CcSEcCtD
Oxaprozin—Insomnia—Docetaxel—lung cancer	0.000105	0.00046	CcSEcCtD
Oxaprozin—Diarrhoea—Cisplatin—lung cancer	0.000104	0.000457	CcSEcCtD
Oxaprozin—Paraesthesia—Docetaxel—lung cancer	0.000104	0.000457	CcSEcCtD
Oxaprozin—Alopecia—Methotrexate—lung cancer	0.000104	0.000456	CcSEcCtD
Oxaprozin—Vomiting—Gemcitabine—lung cancer	0.000104	0.000456	CcSEcCtD
Oxaprozin—Dyspnoea—Docetaxel—lung cancer	0.000103	0.000453	CcSEcCtD
Oxaprozin—Somnolence—Docetaxel—lung cancer	0.000103	0.000452	CcSEcCtD
Oxaprozin—Rash—Gemcitabine—lung cancer	0.000103	0.000452	CcSEcCtD
Oxaprozin—Dermatitis—Gemcitabine—lung cancer	0.000103	0.000451	CcSEcCtD
Oxaprozin—Haemoglobin—Doxorubicin—lung cancer	0.000102	0.000449	CcSEcCtD
Oxaprozin—Headache—Gemcitabine—lung cancer	0.000102	0.000449	CcSEcCtD
Oxaprozin—Dyspepsia—Docetaxel—lung cancer	0.000102	0.000448	CcSEcCtD
Oxaprozin—Hepatitis—Doxorubicin—lung cancer	0.000102	0.000447	CcSEcCtD
Oxaprozin—Haemorrhage—Doxorubicin—lung cancer	0.000102	0.000447	CcSEcCtD
Oxaprozin—Decreased appetite—Docetaxel—lung cancer	0.000101	0.000442	CcSEcCtD
Oxaprozin—Dysgeusia—Methotrexate—lung cancer	0.0001	0.00044	CcSEcCtD
Oxaprozin—Asthenia—Etoposide—lung cancer	0.0001	0.000439	CcSEcCtD
Oxaprozin—Nausea—Irinotecan—lung cancer	9.97e-05	0.000437	CcSEcCtD
Oxaprozin—Constipation—Docetaxel—lung cancer	9.92e-05	0.000435	CcSEcCtD
Oxaprozin—Pruritus—Etoposide—lung cancer	9.88e-05	0.000433	CcSEcCtD
Oxaprozin—Asthenia—Paclitaxel—lung cancer	9.82e-05	0.00043	CcSEcCtD
Oxaprozin—Nausea—Gemcitabine—lung cancer	9.71e-05	0.000426	CcSEcCtD
Oxaprozin—Vomiting—Cisplatin—lung cancer	9.69e-05	0.000425	CcSEcCtD
Oxaprozin—Pruritus—Paclitaxel—lung cancer	9.69e-05	0.000424	CcSEcCtD
Oxaprozin—Vision blurred—Methotrexate—lung cancer	9.66e-05	0.000423	CcSEcCtD
Oxaprozin—Erythema multiforme—Doxorubicin—lung cancer	9.64e-05	0.000422	CcSEcCtD
Oxaprozin—Rash—Cisplatin—lung cancer	9.61e-05	0.000421	CcSEcCtD
Oxaprozin—Dermatitis—Cisplatin—lung cancer	9.6e-05	0.000421	CcSEcCtD
Oxaprozin—Feeling abnormal—Docetaxel—lung cancer	9.56e-05	0.000419	CcSEcCtD
Oxaprozin—Diarrhoea—Etoposide—lung cancer	9.55e-05	0.000419	CcSEcCtD
Oxaprozin—Ill-defined disorder—Methotrexate—lung cancer	9.51e-05	0.000417	CcSEcCtD
Oxaprozin—Tinnitus—Doxorubicin—lung cancer	9.5e-05	0.000416	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Docetaxel—lung cancer	9.49e-05	0.000416	CcSEcCtD
Oxaprozin—Anaemia—Methotrexate—lung cancer	9.47e-05	0.000415	CcSEcCtD
Oxaprozin—Diarrhoea—Paclitaxel—lung cancer	9.37e-05	0.00041	CcSEcCtD
Oxaprozin—Malaise—Methotrexate—lung cancer	9.24e-05	0.000405	CcSEcCtD
Oxaprozin—Dizziness—Etoposide—lung cancer	9.23e-05	0.000405	CcSEcCtD
Oxaprozin—Vertigo—Methotrexate—lung cancer	9.21e-05	0.000403	CcSEcCtD
Oxaprozin—Abdominal pain—Docetaxel—lung cancer	9.17e-05	0.000402	CcSEcCtD
Oxaprozin—Body temperature increased—Docetaxel—lung cancer	9.17e-05	0.000402	CcSEcCtD
Oxaprozin—Leukopenia—Methotrexate—lung cancer	9.17e-05	0.000402	CcSEcCtD
Oxaprozin—Arrhythmia—Doxorubicin—lung cancer	9.11e-05	0.000399	CcSEcCtD
Oxaprozin—Dizziness—Paclitaxel—lung cancer	9.05e-05	0.000397	CcSEcCtD
Oxaprozin—Nausea—Cisplatin—lung cancer	9.05e-05	0.000397	CcSEcCtD
Oxaprozin—Alopecia—Doxorubicin—lung cancer	9.01e-05	0.000395	CcSEcCtD
Oxaprozin—Convulsion—Methotrexate—lung cancer	8.88e-05	0.000389	CcSEcCtD
Oxaprozin—Vomiting—Etoposide—lung cancer	8.88e-05	0.000389	CcSEcCtD
Oxaprozin—Rash—Etoposide—lung cancer	8.8e-05	0.000386	CcSEcCtD
Oxaprozin—Dermatitis—Etoposide—lung cancer	8.8e-05	0.000385	CcSEcCtD
Oxaprozin—Headache—Etoposide—lung cancer	8.75e-05	0.000383	CcSEcCtD
Oxaprozin—Flatulence—Doxorubicin—lung cancer	8.74e-05	0.000383	CcSEcCtD
Oxaprozin—Tension—Doxorubicin—lung cancer	8.71e-05	0.000382	CcSEcCtD
Oxaprozin—Vomiting—Paclitaxel—lung cancer	8.71e-05	0.000381	CcSEcCtD
Oxaprozin—Dysgeusia—Doxorubicin—lung cancer	8.69e-05	0.000381	CcSEcCtD
Oxaprozin—Rash—Paclitaxel—lung cancer	8.63e-05	0.000378	CcSEcCtD
Oxaprozin—Dermatitis—Paclitaxel—lung cancer	8.62e-05	0.000378	CcSEcCtD
Oxaprozin—Discomfort—Methotrexate—lung cancer	8.62e-05	0.000378	CcSEcCtD
Oxaprozin—Nervousness—Doxorubicin—lung cancer	8.62e-05	0.000378	CcSEcCtD
Oxaprozin—Headache—Paclitaxel—lung cancer	8.58e-05	0.000376	CcSEcCtD
Oxaprozin—Methadone—ABCB1—lung cancer	8.54e-05	0.0287	CrCbGaD
Oxaprozin—Confusional state—Methotrexate—lung cancer	8.43e-05	0.00037	CcSEcCtD
Oxaprozin—Anaphylactic shock—Methotrexate—lung cancer	8.36e-05	0.000366	CcSEcCtD
Oxaprozin—Vision blurred—Doxorubicin—lung cancer	8.36e-05	0.000366	CcSEcCtD
Oxaprozin—Asthenia—Docetaxel—lung cancer	8.33e-05	0.000365	CcSEcCtD
Oxaprozin—Infection—Methotrexate—lung cancer	8.31e-05	0.000364	CcSEcCtD
Oxaprozin—Nausea—Etoposide—lung cancer	8.29e-05	0.000363	CcSEcCtD
Oxaprozin—Ill-defined disorder—Doxorubicin—lung cancer	8.23e-05	0.000361	CcSEcCtD
Oxaprozin—Pruritus—Docetaxel—lung cancer	8.21e-05	0.00036	CcSEcCtD
Oxaprozin—Anaemia—Doxorubicin—lung cancer	8.2e-05	0.000359	CcSEcCtD
Oxaprozin—Thrombocytopenia—Methotrexate—lung cancer	8.19e-05	0.000359	CcSEcCtD
Oxaprozin—Nausea—Paclitaxel—lung cancer	8.13e-05	0.000356	CcSEcCtD
Oxaprozin—Hyperhidrosis—Methotrexate—lung cancer	8.09e-05	0.000354	CcSEcCtD
Oxaprozin—Malaise—Doxorubicin—lung cancer	8e-05	0.000351	CcSEcCtD
Oxaprozin—Vertigo—Doxorubicin—lung cancer	7.97e-05	0.000349	CcSEcCtD
Oxaprozin—Anorexia—Methotrexate—lung cancer	7.97e-05	0.000349	CcSEcCtD
Oxaprozin—Syncope—Doxorubicin—lung cancer	7.96e-05	0.000349	CcSEcCtD
Oxaprozin—Leukopenia—Doxorubicin—lung cancer	7.94e-05	0.000348	CcSEcCtD
Oxaprozin—Diarrhoea—Docetaxel—lung cancer	7.94e-05	0.000348	CcSEcCtD
Oxaprozin—Palpitations—Doxorubicin—lung cancer	7.84e-05	0.000344	CcSEcCtD
Oxaprozin—Hypotension—Methotrexate—lung cancer	7.82e-05	0.000342	CcSEcCtD
Oxaprozin—Loss of consciousness—Doxorubicin—lung cancer	7.8e-05	0.000342	CcSEcCtD
Oxaprozin—Convulsion—Doxorubicin—lung cancer	7.69e-05	0.000337	CcSEcCtD
Oxaprozin—Dizziness—Docetaxel—lung cancer	7.67e-05	0.000336	CcSEcCtD
Oxaprozin—Hypertension—Doxorubicin—lung cancer	7.66e-05	0.000336	CcSEcCtD
Oxaprozin—Insomnia—Methotrexate—lung cancer	7.56e-05	0.000331	CcSEcCtD
Oxaprozin—Anxiety—Doxorubicin—lung cancer	7.53e-05	0.00033	CcSEcCtD
Oxaprozin—Paraesthesia—Methotrexate—lung cancer	7.51e-05	0.000329	CcSEcCtD
Oxaprozin—Discomfort—Doxorubicin—lung cancer	7.46e-05	0.000327	CcSEcCtD
Oxaprozin—Dyspnoea—Methotrexate—lung cancer	7.46e-05	0.000327	CcSEcCtD
Oxaprozin—Somnolence—Methotrexate—lung cancer	7.44e-05	0.000326	CcSEcCtD
Oxaprozin—Dry mouth—Doxorubicin—lung cancer	7.39e-05	0.000324	CcSEcCtD
Oxaprozin—Vomiting—Docetaxel—lung cancer	7.38e-05	0.000323	CcSEcCtD
Oxaprozin—Dyspepsia—Methotrexate—lung cancer	7.36e-05	0.000323	CcSEcCtD
Oxaprozin—Rash—Docetaxel—lung cancer	7.32e-05	0.000321	CcSEcCtD
Oxaprozin—Dermatitis—Docetaxel—lung cancer	7.31e-05	0.00032	CcSEcCtD
Oxaprozin—Confusional state—Doxorubicin—lung cancer	7.3e-05	0.00032	CcSEcCtD
Oxaprozin—Decreased appetite—Methotrexate—lung cancer	7.27e-05	0.000319	CcSEcCtD
Oxaprozin—Headache—Docetaxel—lung cancer	7.27e-05	0.000319	CcSEcCtD
Oxaprozin—Anaphylactic shock—Doxorubicin—lung cancer	7.24e-05	0.000317	CcSEcCtD
Oxaprozin—Oedema—Doxorubicin—lung cancer	7.24e-05	0.000317	CcSEcCtD
Oxaprozin—Infection—Doxorubicin—lung cancer	7.2e-05	0.000315	CcSEcCtD
Oxaprozin—Shock—Doxorubicin—lung cancer	7.13e-05	0.000312	CcSEcCtD
Oxaprozin—Thrombocytopenia—Doxorubicin—lung cancer	7.09e-05	0.000311	CcSEcCtD
Oxaprozin—Tachycardia—Doxorubicin—lung cancer	7.07e-05	0.00031	CcSEcCtD
Oxaprozin—Hyperhidrosis—Doxorubicin—lung cancer	7e-05	0.000307	CcSEcCtD
Oxaprozin—Anorexia—Doxorubicin—lung cancer	6.9e-05	0.000303	CcSEcCtD
Oxaprozin—Nausea—Docetaxel—lung cancer	6.89e-05	0.000302	CcSEcCtD
Oxaprozin—Feeling abnormal—Methotrexate—lung cancer	6.89e-05	0.000302	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Methotrexate—lung cancer	6.84e-05	0.0003	CcSEcCtD
Oxaprozin—Hypotension—Doxorubicin—lung cancer	6.77e-05	0.000297	CcSEcCtD
Oxaprozin—Urticaria—Methotrexate—lung cancer	6.64e-05	0.000291	CcSEcCtD
Oxaprozin—Abdominal pain—Methotrexate—lung cancer	6.61e-05	0.00029	CcSEcCtD
Oxaprozin—Body temperature increased—Methotrexate—lung cancer	6.61e-05	0.00029	CcSEcCtD
Oxaprozin—Insomnia—Doxorubicin—lung cancer	6.55e-05	0.000287	CcSEcCtD
Oxaprozin—Paraesthesia—Doxorubicin—lung cancer	6.5e-05	0.000285	CcSEcCtD
Oxaprozin—Dyspnoea—Doxorubicin—lung cancer	6.46e-05	0.000283	CcSEcCtD
Oxaprozin—Somnolence—Doxorubicin—lung cancer	6.44e-05	0.000282	CcSEcCtD
Oxaprozin—Dyspepsia—Doxorubicin—lung cancer	6.38e-05	0.000279	CcSEcCtD
Oxaprozin—Decreased appetite—Doxorubicin—lung cancer	6.3e-05	0.000276	CcSEcCtD
Oxaprozin—Constipation—Doxorubicin—lung cancer	6.19e-05	0.000271	CcSEcCtD
Oxaprozin—Asthenia—Methotrexate—lung cancer	6e-05	0.000263	CcSEcCtD
Oxaprozin—Feeling abnormal—Doxorubicin—lung cancer	5.97e-05	0.000262	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Doxorubicin—lung cancer	5.92e-05	0.00026	CcSEcCtD
Oxaprozin—Pruritus—Methotrexate—lung cancer	5.92e-05	0.000259	CcSEcCtD
Oxaprozin—Urticaria—Doxorubicin—lung cancer	5.75e-05	0.000252	CcSEcCtD
Oxaprozin—Abdominal pain—Doxorubicin—lung cancer	5.73e-05	0.000251	CcSEcCtD
Oxaprozin—Body temperature increased—Doxorubicin—lung cancer	5.73e-05	0.000251	CcSEcCtD
Oxaprozin—Diarrhoea—Methotrexate—lung cancer	5.72e-05	0.000251	CcSEcCtD
Oxaprozin—Dizziness—Methotrexate—lung cancer	5.53e-05	0.000242	CcSEcCtD
Oxaprozin—Vomiting—Methotrexate—lung cancer	5.32e-05	0.000233	CcSEcCtD
Oxaprozin—Rash—Methotrexate—lung cancer	5.27e-05	0.000231	CcSEcCtD
Oxaprozin—Dermatitis—Methotrexate—lung cancer	5.27e-05	0.000231	CcSEcCtD
Oxaprozin—Headache—Methotrexate—lung cancer	5.24e-05	0.00023	CcSEcCtD
Oxaprozin—Asthenia—Doxorubicin—lung cancer	5.2e-05	0.000228	CcSEcCtD
Oxaprozin—Pruritus—Doxorubicin—lung cancer	5.12e-05	0.000225	CcSEcCtD
Oxaprozin—Nausea—Methotrexate—lung cancer	4.97e-05	0.000218	CcSEcCtD
Oxaprozin—Diarrhoea—Doxorubicin—lung cancer	4.96e-05	0.000217	CcSEcCtD
Oxaprozin—Dizziness—Doxorubicin—lung cancer	4.79e-05	0.00021	CcSEcCtD
Oxaprozin—Vomiting—Doxorubicin—lung cancer	4.6e-05	0.000202	CcSEcCtD
Oxaprozin—Rash—Doxorubicin—lung cancer	4.57e-05	0.0002	CcSEcCtD
Oxaprozin—Dermatitis—Doxorubicin—lung cancer	4.56e-05	0.0002	CcSEcCtD
Oxaprozin—Headache—Doxorubicin—lung cancer	4.54e-05	0.000199	CcSEcCtD
Oxaprozin—PTGS1—Metabolism—GSTA3—lung cancer	4.37e-05	0.000704	CbGpPWpGaD
Oxaprozin—Nausea—Doxorubicin—lung cancer	4.3e-05	0.000189	CcSEcCtD
Oxaprozin—PTGS2—Metabolism—CNDP2—lung cancer	4.3e-05	0.000693	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTM2—lung cancer	4.3e-05	0.000693	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	4.24e-05	0.000684	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MTMR3—lung cancer	4.18e-05	0.000675	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—B4GALT5—lung cancer	4.1e-05	0.000662	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	4.1e-05	0.000661	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PGAM1—lung cancer	4.08e-05	0.000657	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SKI—lung cancer	4.01e-05	0.000646	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ATP5H—lung cancer	4e-05	0.000644	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTA4—lung cancer	3.99e-05	0.000644	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	3.99e-05	0.000643	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—POMC—lung cancer	3.98e-05	0.000642	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	3.98e-05	0.000642	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.9e-05	0.000629	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTA2—lung cancer	3.89e-05	0.000628	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—B4GALT5—lung cancer	3.89e-05	0.000627	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP2A7—lung cancer	3.89e-05	0.000627	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TP53—lung cancer	3.86e-05	0.000623	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	3.86e-05	0.000622	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	3.85e-05	0.000621	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SDC4—lung cancer	3.8e-05	0.000614	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTA1—lung cancer	3.75e-05	0.000605	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ABCC3—lung cancer	3.71e-05	0.000599	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3.67e-05	0.000592	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	3.67e-05	0.000592	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AKR1C1—lung cancer	3.59e-05	0.00058	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	3.57e-05	0.000575	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PLBD1—lung cancer	3.56e-05	0.000574	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL6—lung cancer	3.53e-05	0.00057	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.5e-05	0.000565	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—UGT1A1—lung cancer	3.49e-05	0.000563	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PXN—lung cancer	3.48e-05	0.000561	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	3.48e-05	0.000561	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—RRM1—lung cancer	3.47e-05	0.000559	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTA3—lung cancer	3.47e-05	0.000559	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKR1C1—lung cancer	3.41e-05	0.00055	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GNG11—lung cancer	3.37e-05	0.000543	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.35e-05	0.00054	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	3.29e-05	0.00053	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—B4GALT5—lung cancer	3.26e-05	0.000526	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HSD17B10—lung cancer	3.26e-05	0.000525	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALDOA—lung cancer	3.2e-05	0.000517	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	3.2e-05	0.000516	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTA4—lung cancer	3.17e-05	0.000511	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NPPA—lung cancer	3.14e-05	0.000506	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	3.13e-05	0.000504	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NCOA3—lung cancer	3.11e-05	0.000502	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.1e-05	0.0005	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTA2—lung cancer	3.09e-05	0.000498	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PPIA—lung cancer	3.06e-05	0.000494	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.06e-05	0.000493	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ALDOA—lung cancer	3.04e-05	0.00049	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CKB—lung cancer	3.03e-05	0.000488	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ADCY1—lung cancer	3.03e-05	0.000488	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ABCG2—lung cancer	3.03e-05	0.000488	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTA1—lung cancer	2.98e-05	0.000481	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—HPGDS—lung cancer	2.97e-05	0.000479	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ENO2—lung cancer	2.97e-05	0.000479	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	2.95e-05	0.000477	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PPP2R1B—lung cancer	2.95e-05	0.000476	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCC3—lung cancer	2.95e-05	0.000475	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.91e-05	0.000469	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTT1—lung cancer	2.88e-05	0.000464	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ADCY1—lung cancer	2.87e-05	0.000463	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AKR1C1—lung cancer	2.85e-05	0.00046	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTM2—lung cancer	2.85e-05	0.000459	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CNDP2—lung cancer	2.85e-05	0.000459	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GCLC—lung cancer	2.84e-05	0.000459	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP2A6—lung cancer	2.84e-05	0.000459	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.83e-05	0.000457	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ENO2—lung cancer	2.81e-05	0.000454	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PPP2R1B—lung cancer	2.8e-05	0.000451	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SMARCA4—lung cancer	2.8e-05	0.000451	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—UGT1A1—lung cancer	2.77e-05	0.000447	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTMR3—lung cancer	2.77e-05	0.000447	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	2.71e-05	0.000438	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PGAM1—lung cancer	2.7e-05	0.000435	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ENO1—lung cancer	2.7e-05	0.000435	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.69e-05	0.000433	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GNG11—lung cancer	2.67e-05	0.000431	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.66e-05	0.000429	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.65e-05	0.000428	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	2.63e-05	0.000424	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP2A7—lung cancer	2.57e-05	0.000415	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ENO1—lung cancer	2.56e-05	0.000412	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALDOA—lung cancer	2.54e-05	0.00041	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SDC4—lung cancer	2.52e-05	0.000406	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NCOA3—lung cancer	2.47e-05	0.000398	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.43e-05	0.000391	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP2E1—lung cancer	2.42e-05	0.00039	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCG2—lung cancer	2.4e-05	0.000387	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ADCY1—lung cancer	2.4e-05	0.000387	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NQO1—lung cancer	2.39e-05	0.000386	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APP—lung cancer	2.38e-05	0.000383	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF9—lung cancer	2.36e-05	0.00038	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ENO2—lung cancer	2.36e-05	0.00038	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HPGDS—lung cancer	2.36e-05	0.00038	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.34e-05	0.000378	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PPP2R1B—lung cancer	2.34e-05	0.000378	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.32e-05	0.000374	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.31e-05	0.000373	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—RRM1—lung cancer	2.29e-05	0.00037	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA3—lung cancer	2.29e-05	0.00037	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTT1—lung cancer	2.28e-05	0.000369	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP2A6—lung cancer	2.26e-05	0.000364	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GCLC—lung cancer	2.26e-05	0.000364	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—JUNB—lung cancer	2.25e-05	0.000363	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.25e-05	0.000363	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.22e-05	0.000358	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—B4GALT5—lung cancer	2.16e-05	0.000348	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—STK11—lung cancer	2.16e-05	0.000348	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ENO1—lung cancer	2.14e-05	0.000345	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.13e-05	0.000344	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.11e-05	0.00034	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA4—lung cancer	2.1e-05	0.000339	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.05e-05	0.000331	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA2—lung cancer	2.05e-05	0.00033	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.02e-05	0.000326	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTP1—lung cancer	1.99e-05	0.000322	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTA1—lung cancer	1.97e-05	0.000318	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FOXO3—lung cancer	1.97e-05	0.000318	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCC3—lung cancer	1.95e-05	0.000315	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CAT—lung cancer	1.94e-05	0.000313	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.93e-05	0.000311	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP2E1—lung cancer	1.92e-05	0.00031	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NQO1—lung cancer	1.9e-05	0.000306	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AKR1C1—lung cancer	1.89e-05	0.000305	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ABCB1—lung cancer	1.89e-05	0.000305	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.86e-05	0.0003	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—TYMS—lung cancer	1.85e-05	0.000299	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—UGT1A1—lung cancer	1.83e-05	0.000296	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTM1—lung cancer	1.83e-05	0.000296	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GNG11—lung cancer	1.77e-05	0.000285	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.76e-05	0.000284	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HES1—lung cancer	1.75e-05	0.000282	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP1A1—lung cancer	1.74e-05	0.00028	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ERCC2—lung cancer	1.72e-05	0.000278	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—STK11—lung cancer	1.71e-05	0.000276	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALDOA—lung cancer	1.68e-05	0.000272	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NCOA3—lung cancer	1.64e-05	0.000264	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERCC2—lung cancer	1.63e-05	0.000264	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.61e-05	0.000259	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.61e-05	0.000259	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERBB3—lung cancer	1.6e-05	0.000258	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ADCY1—lung cancer	1.59e-05	0.000257	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCG2—lung cancer	1.59e-05	0.000257	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTP1—lung cancer	1.58e-05	0.000255	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ENO2—lung cancer	1.56e-05	0.000252	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HPGDS—lung cancer	1.56e-05	0.000252	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.55e-05	0.00025	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CAT—lung cancer	1.54e-05	0.000249	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.53e-05	0.000247	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TERT—lung cancer	1.53e-05	0.000247	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.53e-05	0.000247	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTT1—lung cancer	1.51e-05	0.000244	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCB1—lung cancer	1.5e-05	0.000242	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GCLC—lung cancer	1.5e-05	0.000241	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP2A6—lung cancer	1.5e-05	0.000241	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—APOA1—lung cancer	1.49e-05	0.00024	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.49e-05	0.00024	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGFR1—lung cancer	1.49e-05	0.00024	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TYMS—lung cancer	1.47e-05	0.000237	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HIF1A—lung cancer	1.46e-05	0.000236	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTM1—lung cancer	1.46e-05	0.000235	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.43e-05	0.00023	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ENO1—lung cancer	1.42e-05	0.000229	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APOA1—lung cancer	1.41e-05	0.000228	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.41e-05	0.000228	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.39e-05	0.000225	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP1A1—lung cancer	1.38e-05	0.000223	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ERCC2—lung cancer	1.37e-05	0.000221	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CG—lung cancer	1.36e-05	0.00022	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—POMC—lung cancer	1.3e-05	0.000209	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APC—lung cancer	1.29e-05	0.000208	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KIT—lung cancer	1.29e-05	0.000208	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EGF—lung cancer	1.28e-05	0.000206	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP2E1—lung cancer	1.27e-05	0.000205	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CREBBP—lung cancer	1.26e-05	0.000204	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NQO1—lung cancer	1.26e-05	0.000203	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.23e-05	0.000199	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.22e-05	0.000197	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—BRAF—lung cancer	1.21e-05	0.000196	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6R—lung cancer	1.2e-05	0.000193	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CD—lung cancer	1.2e-05	0.000193	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CREBBP—lung cancer	1.2e-05	0.000193	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—APOA1—lung cancer	1.18e-05	0.000191	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALB—lung cancer	1.18e-05	0.000191	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAP2K1—lung cancer	1.14e-05	0.000184	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CD—lung cancer	1.13e-05	0.000183	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—STK11—lung cancer	1.13e-05	0.000183	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.13e-05	0.000183	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CG—lung cancer	1.08e-05	0.000174	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.06e-05	0.000172	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTP1—lung cancer	1.05e-05	0.000169	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CB—lung cancer	1.04e-05	0.000168	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTGS2—lung cancer	1.03e-05	0.000167	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—POMC—lung cancer	1.03e-05	0.000166	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CAT—lung cancer	1.02e-05	0.000165	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MDM2—lung cancer	1.02e-05	0.000164	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.01e-05	0.000164	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RAF1—lung cancer	1.01e-05	0.000163	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CREBBP—lung cancer	1e-05	0.000162	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERBB2—lung cancer	1e-05	0.000162	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCB1—lung cancer	9.93e-06	0.00016	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTOR—lung cancer	9.89e-06	0.000159	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CB—lung cancer	9.89e-06	0.000159	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD4—lung cancer	9.87e-06	0.000159	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TYMS—lung cancer	9.75e-06	0.000157	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTM1—lung cancer	9.64e-06	0.000155	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CD—lung cancer	9.5e-06	0.000153	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALB—lung cancer	9.38e-06	0.000151	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP1A1—lung cancer	9.14e-06	0.000147	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ERCC2—lung cancer	9.06e-06	0.000146	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTEN—lung cancer	9.01e-06	0.000145	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—EP300—lung cancer	8.6e-06	0.000139	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN1A—lung cancer	8.56e-06	0.000138	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PTEN—lung cancer	8.54e-06	0.000138	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CB—lung cancer	8.28e-06	0.000134	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EP300—lung cancer	8.15e-06	0.000131	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SRC—lung cancer	7.92e-06	0.000128	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—APOA1—lung cancer	7.84e-06	0.000126	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—STAT3—lung cancer	7.64e-06	0.000123	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NRAS—lung cancer	7.62e-06	0.000123	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.51e-06	0.000121	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAPK3—lung cancer	7.3e-06	0.000118	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CG—lung cancer	7.16e-06	0.000115	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PTEN—lung cancer	7.16e-06	0.000115	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MYC—lung cancer	7.1e-06	0.000115	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EGFR—lung cancer	6.94e-06	0.000112	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—EP300—lung cancer	6.82e-06	0.00011	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—POMC—lung cancer	6.81e-06	0.00011	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CREBBP—lung cancer	6.63e-06	0.000107	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KRAS—lung cancer	6.56e-06	0.000106	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CA—lung cancer	6.36e-06	0.000103	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CD—lung cancer	6.29e-06	0.000101	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALB—lung cancer	6.21e-06	0.0001	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CA—lung cancer	6.03e-06	9.72e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HRAS—lung cancer	5.58e-06	8.99e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CB—lung cancer	5.48e-06	8.84e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTGS2—lung cancer	5.43e-06	8.76e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6—lung cancer	5.34e-06	8.61e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AKT1—lung cancer	5.19e-06	8.38e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CA—lung cancer	5.05e-06	8.14e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKT1—lung cancer	4.92e-06	7.94e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTEN—lung cancer	4.74e-06	7.64e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—EP300—lung cancer	4.52e-06	7.29e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AKT1—lung cancer	4.12e-06	6.65e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CA—lung cancer	3.34e-06	5.39e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AKT1—lung cancer	2.73e-06	4.4e-05	CbGpPWpGaD
